Hangzhou Tigermed Consulting Co., Ltd (SHE:300347)
China flag China · Delayed Price · Currency is CNY
49.66
-0.01 (-0.02%)
Nov 2, 2026, 3:04 PM CST

SHE:300347 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
7,4796,7136,4747,2897,0025,187
Other Revenue
119.47119.47129.0494.9383.9326.17
7,5986,8336,6037,3847,0855,214
Revenue Growth
15.81%3.48%-10.58%4.21%35.91%63.32%
Cost of Revenue
5,6074,9604,3594,5394,2772,943
Gross Profit
1,9921,8732,2442,8452,8082,271
Selling, General & Admin
962.45960.56944.45837.52780.02676.88
Research & Development
273.01257.64238.39261.56234.62211.83
Other Operating Expenses
31.2931.7122.219.157.1712.5
Operating Expenses
1,2581,2651,2351,1551,046926.93
Operating Income
733.36608.471,0091,6901,7631,344
Interest Expense
-80.15-90.56-141.24-119.9-83.18-24.91
Interest & Investment Income
38.05448.94256.86568.02330.09568.16
Currency Exchange Gain (Loss)
-16.95-16.9518.022.6120.13-11.83
Other Non Operating Income (Expenses)
-5.32-9.26-6.59-3.32-6.88-1.48
EBT Excluding Unusual Items
668.99940.641,1372,1382,0231,874
Impairment of Goodwill
-20.28-20.28-5-29.16--
Gain (Loss) on Sale of Investments
-877.9142.26-501.69352.77535.861,815
Gain (Loss) on Sale of Assets
-17.643.653.56-0.19-0.09-0.53
Asset Writedown
0.01-0.22---0.45-
Other Unusual Items
37.1637.1631.0527.2427.1-3.96
Pretax Income
-209.671,003664.462,4892,5853,685
Income Tax Expense
201.01198.16216.63338.61313.65292.86
Earnings From Continuing Operations
-410.68805.06447.832,1502,2723,392
Minority Interest in Earnings
6.0882.83-42.69-125.08-265.17-517.54
Net Income
-404.59887.89405.142,0252,0072,874
Net Income to Common
-404.59887.89405.142,0252,0072,874
Net Income Growth
-119.15%-79.99%0.91%-30.19%64.26%
Shares Outstanding (Basic)
850856863865865868
Shares Outstanding (Diluted)
850856863865866871
Shares Change
-0.79%-0.83%-0.22%-0.07%-0.62%9.01%
EPS (Basic)
-0.481.040.472.342.323.31
EPS (Diluted)
-0.481.040.472.342.323.30
EPS Growth
-120.99%-79.94%0.86%-29.70%50.69%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
977.91903.72740.45836.68908.91,055
Free Cash Flow Per Share
1.151.060.860.971.051.21
Dividend Per Share
0.1260.1260.3000.5680.5500.500
Dividend Growth
-58.00%-58.00%-47.18%3.27%10.00%66.67%
Gross Margin
26.21%27.41%33.99%38.53%39.64%43.55%
Operating Margin
9.65%8.91%15.29%22.89%24.88%25.77%
Profit Margin
-5.33%13.00%6.14%27.42%28.32%55.13%
Free Cash Flow Margin
12.87%13.23%11.21%11.33%12.83%20.24%
EBITDA
950.16820.31,2151,8761,9211,458
EBITDA Margin
12.50%12.01%18.40%25.40%27.12%27.97%
D&A For EBITDA
216.8211.84205.22185.06158.69114.71
EBIT
733.36608.471,0091,6901,7631,344
EBIT Margin
9.65%8.91%15.29%22.89%24.88%25.77%
Effective Tax Rate
-19.75%32.60%13.61%12.13%7.95%
Revenue as Reported
7,5986,8336,6037,3847,0855,214
Advertising Expenses
-13.0514.119.9719.2414.45